QIAGEN has enhanced its mRNA/lncRNA profiling assays and panels with LNA technology and optimized with QuantiNova chemistry to create a comprehensive new portfolio for highly sensitive and specific gene expression analysis. These two new PCR systems offer the choice of SYBR® Green or hydrolysis probe-based detection and provide the broadest coverage of predesigned human, mouse and rat assays and panels. For specialized applications, researchers can easily create custom assays and panels online in GeneGlobe. In this webinar, we will discuss the principles behind the design and high performance of these new LNA-enhanced assays and show how they are setting a new standard in mRNA/lncRNA qPCR expression analysis.
About the speaker
Marie-Louise Lunn, Associate Director in Global Product Management
Marie-Louise Lunn is Associate Director in Global Product Management at QIAGEN with a focus on the gene expression assay portfolio. She holds a Ph.D. in molecular neurobiology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in San Diego, USA, she joined Exiqon Sales and Marketing in 2006 and has been with QIAGEN since the acquisition of Exiqon in 2017.
Date of recording:Tuesday, 9 March 2021
Duration:40 minutes
Real time PCR